Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
| Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination |
| Autore | Alix-Panabieres Catherine |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (366 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
abiraterone
ACCEPT androgen receptor AR AR-V7 ARV7 biomarker biomarkers bone marrow breast cancer castration resistant prostate cancer (CRPC) CD133 CellSearch CellSearch® cerebrospinal liquid biopsy chemoradioresistance chromogranin A circulating leukemia cells circulating plasma cells circulating tumor cells circulating tumor cells (CTC) circulating tumor cells (CTCs) circulating tumor DNA circulating tumour cells clinical trials clinical utility colorectal cancer colorectal surgery CTC CTC biology CTC capture technology CTC-based treatment decisions CTC-derived ex vivo models CTC-derived xenografts CTCs ctDNA CTM CTMat ctRNA disseminated tumor cells early breast cancer EasyCount slides emboli enrichment and detection technologies enzalutamide EpCAM enrichment EPISPOT epithelial-mesenchymal transition epithelial-to-mesenchymal transition (EMT) exosome exosomes fibronectin fish flow cytometry FOLFIRINOX gene expression analysis glioma hematological cells hepatocellular carcinoma (HCC) heterogeneity HMB-45 immune checkpoint inhibitors immune system immunofluorescence imaging immunomodulation immunophenotyping in vivo flow cytometry integrin B1 leukocyte-derived extracellular vesicles liquid biopsy liquid surgery locally advanced rectal cancer major histocompatibility complex class I (MHCI) malaria melanoma metastasis metastatic colorectal cancer microbiome microfluidics microsatellite instability miRNA n/a neutrophils NSCLC PD-L1 expression platelets prostate cancer prostate cancer (PCa) RAD23B rovalpituzumab tesirine rVAR2 single-cell analysis SLUG small-cell lung carcinoma solid cancers stem cells synaptophysin targeted therapy thymidylate synthase tumor biomarkers tumor cell dissemination tumor stem cells tumor-initiating cells (TICs) xenograft models |
| ISBN | 3-03928-699-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Circulating Tumor Cells |
| Record Nr. | UNINA-9910404091403321 |
Alix-Panabieres Catherine
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Gastrointestinal Cancers and Personalized Medicine
| Gastrointestinal Cancers and Personalized Medicine |
| Autore | Mini Enrico |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (136 p.) |
| Soggetto topico |
Medicine and Nursing
Pharmacology |
| Soggetto non controllato |
biomarker
chemotherapy-induced peripheral neuropathy colon cancer colorectal cancer diagnosis differential scanning calorimetry FFPE FOLFIRINOX FOLFOX gastrointestinal cancer gene signature generalized linear models genomics immune checkpoint immunotherapy LAG-3 lymphocyte-to-monocyte ratio mesorectum microsatellite instability molecular oncology molecular profiling mRNA expression n/a neuropathy neurotoxicity neutrophil-to-lymphocyte ratio oxaliplatin pancreatic cysts precision medicine prognosis rectal cancer sphincter preserving survival targeted therapy thermal liquid biopsy VANGL1 XELOX |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566485503321 |
|
Mini Enrico
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Killing Cancer : Discovery and Selection of New Target Molecules
| Killing Cancer : Discovery and Selection of New Target Molecules |
| Autore | Kallunki Tuula |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (302 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
3D growth
ABCG2 AF1Q anoikis ATP-binding cassette transporter ATP6V0a3 ATR pathway autophagy BRCA1 BRCA2 breast cancer resistance protein (BCRP) breast cancer stem cells C2 domain cancer cancer metabolism cancer therapy CD domain chondroitin sulfate colorectal cancer dexamethasone disulfiram DNA damage drug efflux pumps dysferlin EMT epithelial-mesenchymal transition ERK1 ERK2 esophageal cancer ferlin glucocorticoids IL-8 immunotherapy inflammation invasion kinase inhibitors lysosome lysosome-mediated invasion mammosphere MAPK kinase matrix degradation metabolism microgravity microsatellite instability migration MLLT11 mTOR in immunotherapy mTOR inhibitors mTOR signaling mTORC1 mTORC2 multidrug resistance in cancer myoferlin MZF1 n/a NF-κB NPL4 nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB) nutrient metabolism oncofetal chondroitin sulfate otoferlin PAK4 PDAC pediatric cancer pH-regulation phosphorylation plasma membrane prognosis proliferation pyrazolo-pyrimidine derivative rapalogs replication stress Rolled SCH772984 SCO-201 sevenmaker solid tumors space environment STAT sulconazole SUMOylation target targeted cancer therapy TCIRG1 thyroid cancer transcription factor VAR2 VRT-11E WNT zinc finger |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Killing Cancer |
| Record Nr. | UNINA-9910557648103321 |
|
Kallunki Tuula
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer
| Mechanisms and Novel Therapeutic Approaches for Gynecologic Cancer |
| Autore | Nakayama Naomi |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (258 p.) |
| Soggetto topico | Public health and preventive medicine |
| Soggetto non controllato |
adoptive immunotherapy
anti-angiogenic therapy aryl hydrocarbon receptor BEN (BANP, E5R and NAC1) domain biological planning biomarkers borderline ovarian tumors BRCA1 mutant ovarian cancer cancer progression CD44 cervical cancer cervical neoplasia chimeric antigen receptor clear cell carcinoma differentially expressed genes DNA damage response DNA mismatch repair (MMR) drug repurposing endometrial cancer endometrial carcinoma endometrioid endometrial cancer epithelial ovarian cancer epithelial ovarian cancers epithelial-mesenchymal transition exosome gene ontology gynecological cancer HDR brachytherapy human cytomegalovirus immune checkpoints inhibitors immune micro-environment immunohistochemistry immunosuppression in vivo dosimetry inflammation integrative analysis interventional radiotherapy isothermal titration calorimetry (ITC) liquid biopsy long-term survival melanoma treatment microsatellite instability miRNA mismatch repair deficiency MMR deficient (dMMR) n/a nanocarriers NK cells non-coding RNAs nucleus accumbens-associated protein 1 (NAC1) ovarian cancer p16 protein pGSK3β PLA2G7) platelet-activating factor acetylhydrolase (PAF-AH prognosis sequence-specific DNA-binding protein solution NMR structure somatic mutation targeted therapy testin vaginal melanoma vaginal-cuff brachytherapy vulvar melanoma Wnt signaling β-catenin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910580209103321 |
|
Nakayama Naomi
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metastatic Progression and Tumour Heterogeneity
| Metastatic Progression and Tumour Heterogeneity |
| Autore | Hollande Fred |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (312 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
3D cultures
acidosis ADH angiocrine factor beta-catenin paradox biomechanics breast cancer carbonic anhydrase cell fate cellular heterogeneity circulating tumor cells circulating tumor cells (CTCs) clear cell renal cell carcinoma clonality collective and single-cell migration colon cancer colorectal cancer CTC-clusters DCIS deficient mismatch repair EMT endometrial carcinoma epigenetics epithelial mesenchymal plasticity epithelial-to-mesenchymal transition esophageal squamous cell carcinoma extracellular vesicles gene expression genomics heterogeneity hybrid E/M hyperpolarized 13C MRI immune checkpoints immune microenvironment immunotherapy interstitial pH intra-tumour heterogeneity intratumor heterogeneity lactic acid magnetic resonance imaging mammary gland metaplastic carcinoma metastasis metastatic niche microsatellite instability miRNA expression multisite tumor sampling mutation natural killer cells nuclear medicine organoids pancreatic cancer PET phenotypic plasticity PI3K/AKT pathway plasticity positron emission tomography precision medicine radiomics radiopharmaceuticals review signaling single-cell analysis single-cell RNAseq subclonal diversity SUV target discovery targeted therapy TP53 treatment resistance tumor ecology tumor endothelial cell tumor evolution tumor heterogeneity tumor microenvironment tumor mutation burden uterine carcinosarcoma Wnt signaling |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557105803321 |
|
Hollande Fred
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Multimodality Treatments in Metastatic Gastric Cancer
| Multimodality Treatments in Metastatic Gastric Cancer |
| Autore | Petrillo Angelica |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (162 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
advanced gastric cancer
biomarkers body composition bone flare CAR T cell therapy cfDNA circulating tumor cell conversion surgery ctDNA epithelial-mesenchymal transition Epstein Barr Virus exome sequencing formalin fixed paraffin embedded gastric cancer gastro-oesophageal cancer hepatectomy HER2-inhibition immune checkpoint inhibitors immunotherapy liquid biopsy liver metastasis metastatic metastatic gastric cancer microsatellite instability mutational concordance n/a new drug development nutritional status outcome precision medicine predictive biomarkers RANK-L resistance to treatment response monitoring sarcopenia stage IV stage iv gastric cancer subcutaneous fat area target therapy toxicity treatment tumor mutational burden vaccines VEGFR-inhibition visceral fat area |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557390503321 |
|
Petrillo Angelica
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||